United Therapeutics Corporation Announces $1 Billion Share Repurchase Program

SEC Filing 8-K (0001104659-25-073163)

United Therapeutics Corporation has entered into two accelerated share repurchase agreements with Citibank, N.A., totaling $1 billion. The agreements are part of a previously announced share repurchase program approved by the company's board of directors. Under the agreements, United Therapeutics will make an upfront payment of $1 billion on August 4, 2025. The company will receive an initial delivery of shares, with the final number of shares to be repurchased determined based on the average daily volume-weighted average price of the company's common stock during the term of the agreements. The transactions are expected to be settled in the fourth quarter of 2025 and the first quarter of 2026, respectively.